CytoTronics has developed an innovative technology known as Pixel™, which significantly enhances the capabilities of cell biology research. This system utilizes a semiconductor-to-live-cell interface that allows for unprecedented insights into live-cell functions. By enabling multiplexed live-cell readouts, Pixel™ can simultaneously monitor various cellular parameters such as viability, morphology, electrophysiology, and metabolism across any cell type, including spheroids and 3D organoid systems. This versatility empowers researchers to conduct experiments at a scale and depth previously unattainable, facilitating advancements in therapeutic areas like vascular biology, stem cell differentiation, cardiovascular and neurological diseases, and oncology.

The Pixel™ system is designed for scalability and efficiency, allowing exploratory assays to be easily expanded from a single plate to fully-validated applications suitable for industrial-scale operations. It captures thousands of measurements per cell, generating high-dimensional data complemented by spatial images and longitudinal videos. Additionally, the cloud-based software associated with Pixel™ provides rapid analysis of these data-rich live-cell measurements, offering a comprehensive view of cell behavior. This combination of features positions Pixel™ as a transformative tool in the field of cell biology, enabling scientists to reimagine their experimental approaches and unlock new research possibilities.

United States

CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by microchips.

CytoTronics

Company Details